265 related articles for article (PubMed ID: 18971100)
41. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
Wu JF; Ho MC; Ni YH; Chen HL; Lu CY; Hsu HY; Lee PH; Chang MH
Transplantation; 2009 Mar; 87(5):758-62. PubMed ID: 19295323
[TBL] [Abstract][Full Text] [Related]
42. Post-transplant lymphoproliferative disorder presenting as epistaxis.
Clarke JD; Stock D; Singh V
J Laryngol Otol; 2004 Nov; 118(11):906-8. PubMed ID: 15638984
[TBL] [Abstract][Full Text] [Related]
43. Unusual case of Epstein-Barr virus DNA tissue positive: blood negative in a patient with post-transplant lymphoproliferative disorder.
Levenson BM; Ali SA; Timmons CF; Mittal N; Muthukumar A; Payne DA
Pediatr Transplant; 2009 Feb; 13(1):134-8. PubMed ID: 18482217
[TBL] [Abstract][Full Text] [Related]
44. Posttransplant lymphoproliferative disorder in the wall of a lymphocele: a case report.
Basic-Jukic N; Kes P; Coric M; Kastelan Z; Pasini J; Bubic-Filipi L
Transplant Proc; 2009 Jun; 41(5):1966-8. PubMed ID: 19545769
[TBL] [Abstract][Full Text] [Related]
45. Late-onset Epstein-Barr virus-negative post-transplant lymphoproliferative disorder presenting as ulcerated necrotic papules and nodules in a renal transplant patient.
Tang MB; Tan ES; Tan SH
Australas J Dermatol; 2008 May; 49(2):100-2. PubMed ID: 18412811
[TBL] [Abstract][Full Text] [Related]
46. Use of an immune function assay to monitor immunosuppression for treatment of post-transplant lymphoproliferative disorder.
Gautam A; Morrissey PE; Brem AS; Fischer SA; Gohh RY; Yango AF; Monaco AP
Pediatr Transplant; 2006 Aug; 10(5):613-6. PubMed ID: 16856999
[TBL] [Abstract][Full Text] [Related]
47. [Post-transplantation lymphoproliferation in patients with intensive immunosuppression].
Vavrinová H; Viklický O; Lácha J; Housa D; Hosková L; Teplan V
Vnitr Lek; 2006 Jun; 52(6):645-8. PubMed ID: 16871771
[TBL] [Abstract][Full Text] [Related]
48. Post-transplant lymphoproliferative disorders after heart or kidney transplantation at a single centre: presentation and response to treatment.
Aversa SM; Stragliotto S; Marino D; Calabrese F; Rigotti P; Marchini F; Gambino A; Feltrin G; Boso C; Canova F; Soldà C; Mazzarotto R; Burra P
Acta Haematol; 2008; 120(1):36-46. PubMed ID: 18797163
[TBL] [Abstract][Full Text] [Related]
49. Posttransplant lymphoproliferative disease presenting as sudden respiratory arrest in a three-year-old child.
Hague K; Catalano P; Rothschild M; Strauchen J; Fyfe B
Ann Otol Rhinol Laryngol; 1997 Mar; 106(3):244-7. PubMed ID: 9078939
[TBL] [Abstract][Full Text] [Related]
50. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
[TBL] [Abstract][Full Text] [Related]
51. Intestinal perforation associated with rituximab therapy for post-transplant lymphoproliferative disorder after liver transplantation.
Cornejo A; Bohnenblust M; Harris C; Abrahamian GA
Cancer Chemother Pharmacol; 2009 Sep; 64(4):857-60. PubMed ID: 19588139
[TBL] [Abstract][Full Text] [Related]
52. [CME: Lymphoproliferative diseases after transplantation (PTLD)].
Bader P; Giudici L; Benden C
Praxis (Bern 1994); 2016 Feb; 105(3):123-8; quiz 129-30. PubMed ID: 26837319
[No Abstract] [Full Text] [Related]
53. Plasmacytic hyperplasia--the early form of posttransplant lymphoproliferative disorder--with atypical morphology and clinical course in patient after liver transplantation: a case report.
Ziarkiewicz-Wróblewska B; Górnicka B; Ołdakowska U; Suleiman W; Pratnicki A; Szymańska-Giemza O; Ziołkowski J; Senatorski G; Pacholczyk M; Łagiewska B; Rowiński W; Paczek L; Wasiutyński A
Transplant Proc; 2003 Sep; 35(6):2320-2. PubMed ID: 14529928
[TBL] [Abstract][Full Text] [Related]
54. Carcinoma of donor origin after liver-intestine transplantation in a child.
Seda Neto J; Macedo C; Jaffe R; Mazariegos GV; Sindhi R; Bond GJ; Abu-Elmagd K; Reyes J
Pediatr Transplant; 2005 Apr; 9(2):244-8. PubMed ID: 15787801
[TBL] [Abstract][Full Text] [Related]
55. Post-transplant lymphoproliferative disorder after pediatric liver transplantation: characteristics and outcome.
Fernández MC; Bes D; De Dávila M; López S; Cambaceres C; Dip M; Imventarza O
Pediatr Transplant; 2009 May; 13(3):307-10. PubMed ID: 18346039
[TBL] [Abstract][Full Text] [Related]
56. Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders.
Borenstein J; Pezzella F; Gatter KC
Histopathology; 2007 Dec; 51(6):774-7. PubMed ID: 17944927
[TBL] [Abstract][Full Text] [Related]
57. Airway plaque presenting after alteration of immunosuppression in a pediatric patient remote from heart transplantation.
Ryan TD; Absalon MJ; de Alarcon A; Gupta A; Peters AL; Lorts A; Danziger-Isakov LA; Chin C
Pediatr Transplant; 2017 Nov; 21(7):. PubMed ID: 28836710
[TBL] [Abstract][Full Text] [Related]
58. Lymphoproliferative disease seen as a cardiac mass after orthotopic heart transplantation.
Ouseph R; Denny DM; Erbeck KM
J Am Soc Echocardiogr; 1998 Jul; 11(7):758-60. PubMed ID: 9692534
[TBL] [Abstract][Full Text] [Related]
59. Post-transplant lymphoproliferative disorders presenting as gingival overgrowth in patients immunosuppressed with ciclosporin. A report of two cases.
Rolland SL; Seymour RA; Wilkins BS; Parry G; Thomason JM
J Clin Periodontol; 2004 Jul; 31(7):581-5. PubMed ID: 15191596
[TBL] [Abstract][Full Text] [Related]
60. Cardiac allograft involvement by post-transplantation lymphoproliferative disorder.
Nelson KH; Chatzizisis YS; Steigner ML; Mitchell RN; Blankstein R; Givertz MM
J Am Coll Cardiol; 2013 Sep; 62(10):937. PubMed ID: 23850919
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
